A flexible framework for minimal biomarker signature discovery from clinical omics studies without library size normalisation
PLOS Digital Health · 26.03.2025 · 4 (3) · e0000780
DOI: 10.1371/journal.pdig.0000780 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Digital Health, online erschienen am 26.03.2025. Verfasst von Daniel Rawlinson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Application of transcriptomics, proteomics and metabolomics technologies to clinical cohorts has uncovered a variety of signatures for predicting disease. Many of these signatures require the full ‘omics data for evaluation on unseen samples, either explicitly or implicitly through library size normalisation. Translation to low-cost point-of-care tests requires development of signatures which measure as few analytes as possible without relying on direct measurement of library size. To achieve this, we have developed a feature selection method (Forward Selection-Partial Least Squares) which generates minimal disease signatures from high-dimensional omics datasets with applicability to continuous, binary or multi-class outcomes. Through extensive benchmarking, we show that FS-PLS has comparable performance to commonly used signature discovery methods while delivering signatures which are an order of magnitude smaller. We show that FS-PLS can be used to select features predictive of library size, and that these features can be used to normalize unseen samples, meaning that the features in the complete model can be measured in isolation for making new predictions. By enabling discovery of small, high-performance signatures, FS-PLS addresses an important impediment for the further development of precision medical care.
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
- Melbourne Integrative Genomics, School of Mathematics and Statistics, University of Melbourne, Melbourne, Australia.
- Department of Genetics, University of Cambridge, Cambridge, United Kingdom.
- Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
- Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
- Department of Clinical Pathology, University of Melbourne, Melbourne, Australia.
ORCID-Profile: Chenxi Zhou, Lachlan J M Coin
Förderung
- National Health and Medical Research Council
Zitieren
APA
Rawlinson, D., Zhou, C., Kaforou, M., Cao, K. L., Coin, L. J. M., & RAPIDS Study Group (2025). A flexible framework for minimal biomarker signature discovery from clinical omics studies without library size normalisation. PLOS Digital Health, 4(3), e0000780. https://doi.org/10.1371/journal.pdig.0000780
Vancouver
Rawlinson D, Zhou C, Kaforou M, Cao KL, Coin LJM, RAPIDS Study Group. A flexible framework for minimal biomarker signature discovery from clinical omics studies without library size normalisation. PLOS Digital Health. 2025;4(3):e0000780. doi:10.1371/journal.pdig.0000780
BibTeX
@article{Rawlinson2025,
author = {Rawlinson, Daniel and Zhou, Chenxi and Kaforou, Myrsini and Cao, Kim-Anh Lê and Coin, Lachlan J M and RAPIDS Study Group, RAPIDS Study Group},
title = {A flexible framework for minimal biomarker signature discovery from clinical omics studies without library size normalisation},
journal = {PLOS Digital Health},
year = {2025},
volume = {4},
number = {3},
pages = {e0000780},
doi = {10.1371/journal.pdig.0000780}
}
EUVIMED